Safety and Immunogenicity of the ChadOx1 nCoV-19 (AZD1222) Vaccine in Children Aged 12-17 Years: A Preliminary Report of a Phase 2, Single-Blind, Randomised Controlled Trial (COV006)
- Resource Type
- Source
- SSRN Electronic Journal.
- Subject
- Language
- ISSN
- 1556-5068